] The Federal Trade Commission has charged a Utah-based
] company, five related corporations, and three individuals
] operating as a common enterprise with making numerous
] false and unsubstantiated claims for weight-loss and
] fat-loss gels and supplements. The complaint focuses on
] six of the respondents%u2019 heavily promoted products:
] Dermalin, Cutting Gel, and Tummy Flattening Gel (topical
] fat-loss gels with the same active ingredient); Leptoprin
] and Anorex (identical weight-loss supplements for
] %u201Csignificantly overweight%u201D people which
] contained ECA [ephedrine, caffeine and aspirin], an
] additional patented ingredient and calcium); and
] PediaLean (a glucomannan weight-loss supplement for
] children). In an administrative complaint announced
] today, the FTC alleges that the respondents violated the
] FTC Act by making unsubstantiated fat and weight loss
] claims, false claims that clinical testing proves certain
] efficacy claims, and false claims that Daniel B. Mowrey,
] Ph.D, is a medical doctor.

Having seen the commercial for "Leptoprin" dozens of times
on late night TV, I just had to know what was up... nice
to see the feds going after these people for once.